Review
Copyright ©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Table 6 Cold snare polypectomy
Ref.
Year
Country
Study design
n
Polyp morphology
Procedure
Medication
Relative risk
Paspatis et al[27]2011GreeceProspective530Polyp size 3-8 mmCSPNo medicationsNo incidence of PPB. Incidence of immediate/intraprocedural bleeding 9.1%
Ichise et al[44]2011JapanProspective101Polyp size < 8 mmCSPNo medicationsNo incidence of PPB
Gómez et al[37]2015United StatesProspective21Polyp size < 6 mmCSPNo medicationsNo incidence of PPB
Choksi et al[51]2015United StatesRetrospective15Polyp size ≥ 10 mmCSPNo medicationsNo incidence of PPB
Muniraj et al[52]2015United StatesRetrospective12Polyp size ≥ 10 mmCSPNo medicationsNo incidence of PPB
Piraka et al[53]2017United StatesRetrospective94Polyp size ≥ 10 mmCSPNo medicationsNo incidence of PPB
Hirose et al[54]2017JapanRetrospective125Polyp size ≥ 10 mmCSPNo medicationsNo incidence of PPB
Tutticci et al[55]2018AustraliaProspective163Polyp size ≥ 10 mmCSPNo medicationsNo incidence of PPB
Zhang et al[48]2018ChinaProspective212Polyp size 6-9 mmCSPNo medicationsNo incidence of PPB. Incidence of immediate/intraprocedural bleeding 2.7%
Suzuki et al[38]2018JapanProspective25Polyp size ≤ 10 mmCSPNo medicationsNo incidence of PPB
Kawamura et al[39]2018JapanProspective394Polyp size 4-9 mmCSPNo medicationsNo incidence of PPB. Incidence of immediate/intraprocedural bleeding 7.1%
Ket et al[40]2020AustraliaRetrospective346Polyp size 10-20 mmCSPNo medicationsNo incidence of PPB